Business
Opening of United States East Coast Headquarters
Opening of United States East Coast Headquarters.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 4380F\n Creo Medical Group PLC\n 16 July 2021\n \n \n \n \n \n \n \n Creo Medical Group plc\n \n \n (\"Creo\" or the \"Company\")\n \n \n \n \n Opening of United States, East Coast Headquarters \n \n Connecticut site features a learning centre and fully equipped training laboratory to provide on-site immersive, didactic ex-vivo, training sessions supporting Creo's education led commercialisation strategy\n \n \n Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of surgical endoscopy, announces that it has opened its United States headquarters at the Summit, Danbury, Connecticut, USA. \n \n \n \n \n \n The space is designed to support Creo's global growth and focus in the key United States market and features a learning centre and a fully equipped laboratory for clinical development and training purposes which will support Creo's education led commercialisation strategy and enable healthcare providers to participate in immersive, didactic ex-vivo training sessions. United States customer service, finance, product logistics, distribution and other day-to-day functions will also be based in the Danbury, Connecticut, office. Located, northeast of New York city, the office's proximity to international airports provides convenient access for visiting clinicians and members of staff.\n \n \n \n \n \n Over the past 18 months, Creo has established a direct commercial team in the \n United States, led by experienced and successful leaders in market development. The Company also has a US Director of Clinical Education, assisted by Clinical Support Specialists, responsible for ensuring safe and effective use of our product platform and devices. \n \n \n \n \n \n Creo's CROMA Energy Generator platform is in place at multiple academic institutions across the \n United States, with key opinion leaders trained through Creo's Clinical Education Programme. These centres have treated our first patients in the United States and have been identified as \"Centres of Excellence for the operation of our Clinical Education Programme.\" They will be key training sites to educate the second wave of United States clinical users. We intend to increase the number of United States installations and training centres to support t...